Bold, an AI-enabled healthy ageing company, has expanded its virtual weight management programme for seniors to include GLP-1 prescriptions. The service, launched as part of the CMS Bridge programme, combines medication with personalised strength training, nutrition support, and ongoing provider care to address muscle loss risks in older adults. The programme pairs GLP-1 drugs with comprehensive lifestyle support designed to preserve muscle mass and reduce frailty. Bold will prescribe only FDA-approved drugs without markup, prioritising safety and affordability. Members receive monthly check-ins with care teams and access to providers through Bold's app. Bold works with Medicare Advantage plans and ACOs, serving over 12 million eligible seniors. The company reports clinical results showing up to $1,500 in cost reduction within a year and up to 40% reduction in falls and related hospitalisations.

Bold, an AI-enabled healthy aging company for seniors, has appointed Dr Sandeep Palakodeti as chief medical officer. He will expand Bold's care model, build relationships with Medicare Advantage plans and accountable care organisations, and drive clinical outcomes across diverse populations including polychronic and dual-eligible members. Dr Palakodeti brings over 20 years of experience in value-based care and healthcare innovation. He previously served as founding chief medical officer at Hopscotch Health and held leadership positions at Mayo Clinic, University Hospitals and CareMore Health. Bold partners with Medicare Advantage plans and accountable care organisations to improve outcomes for ageing populations, serving over 12 million eligible seniors. The company reports up to $1,500 in total cost of care reduction within a year and up to 40% reduction in falls and related hospitalisations.